SECTION 2. Section 481.1021,
Health and Safety Code, is amended to read as follows:
Sec. 481.1021. PENALTY GROUP
1-A. (a) Penalty Group 1-A consists of:
(1) lysergic acid
diethylamide (LSD), including its salts, isomers, and salts of isomers;
and
(2) compounds
structurally derived from 2,5-dimethoxyphenethylamine by substitution at
the 1-amino nitrogen atom with a benzyl substituent, including:
(A) compounds further
modified by:
(i) substitution in the
phenethylamine ring at the 4- position to any extent (including alkyl,
alkoxy, alkylenedioxy, haloalkyl, or halide substituents); or
(ii) substitution in the
benzyl ring to any extent (including alkyl, alkoxy, alkylenedioxy,
haloalkyl, or halide substituents); and
(B) by example, compounds
such as:
4-Bromo-2,5-dimethoxy-N-(2-
methoxybenzyl)phenethylamine (trade or other names: 25B-NBOMe, 2C-B-NBOMe);
4-Chloro-2,5-dimethoxy-N-(2-
methoxybenzyl)phenethylamine (trade or other names: 25C-NBOMe, 2C-C-NBOMe);
2,5-Dimethoxy-4-methyl-N-(2-
methoxybenzyl)phenethylamine (trade or other names: 25D-NBOMe, 2C-D-NBOMe);
4-Ethyl-2,5-dimethoxy-N-(2-
methoxybenzyl)phenethylamine (trade or other names: 25E-NBOMe, 2C-E-NBOMe);
2,5-Dimethoxy-N-(2-
methoxybenzyl)phenethylamine (trade or other
names: 25H-NBOMe, 2C-H-NBOMe);
4-Iodo-2,5-dimethoxy-N-(2-
methoxybenzyl)phenethylamine (trade or
other names: 25I-NBOMe, 2C-I-NBOMe);
4-Iodo-2,5-dimethoxy-N-
benzylphenethylamine (trade or other name: 25I-NB);
4-Iodo-2,5-dimethoxy-N-(2,3-
methylenedioxybenzyl)phenethylamine (trade or other name: 25I-NBMD);
4-Iodo-2,5-dimethoxy-N-(2-
fluorobenzyl)phenethylamine (trade or other name: 25I-NBF);
4-Iodo-2,5-dimethoxy-N-(2-
hydroxybenzyl)phenethylamine (trade or other name: 25I-NBOH);
2,5-Dimethoxy-4-nitro-N-(2-
methoxybenzyl)phenethylamine (trade or other names: 25N-NBOMe, 2C-N-NBOMe);
and
2,5-Dimethoxy-4-(n)-propyl-N-(2-
methoxybenzyl)phenethylamine (trade or
other names: 25P-NBOMe, 2C-P-NBOMe).
(b) To the extent
Subsection (a)(2) conflicts with this subtitle or another law, the subtitle
or other law prevails.
|
SECTION 2. Section 481.1021,
Health and Safety Code, is amended to read as follows:
Sec. 481.1021. PENALTY GROUP
1-A. (a) Penalty Group 1-A consists of:
(1) lysergic acid
diethylamide (LSD), including its salts, isomers, and salts of isomers;
and
(2) compounds
structurally derived from 2,5-dimethoxyphenethylamine by substitution at
the 1-amino nitrogen atom with a benzyl substituent, including:
(A) compounds further
modified by:
(i) substitution in the
phenethylamine ring at the 4- position to any extent (including alkyl,
alkoxy, alkylenedioxy, haloalkyl, or halide substituents); or
(ii) substitution in the
benzyl ring to any extent (including alkyl, alkoxy, alkylenedioxy,
haloalkyl, or halide substituents); and
(B) by example, compounds
such as:
4-Bromo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine
(trade or other names: 25B-NBOMe, 2C-B-NBOMe);
4-Chloro-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine
(trade or other names: 25C-NBOMe, 2C-C-NBOMe);
2,5-Dimethoxy-4-methyl-N-(2-methoxybenzyl)phenethylamine
(trade or other names: 25D-NBOMe, 2C-D-NBOMe);
4-Ethyl-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine
(trade or other names: 25E-NBOMe, 2C-E-NBOMe);
2,5-Dimethoxy-N-(2-
methoxybenzyl)phenethylamine (some trade
and other names: 25H-NBOMe, 2C-H-NBOMe);
4-Iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine
(some trade and other names:
25I-NBOMe, 2C-I-NBOMe);
4-Iodo-2,5-dimethoxy-N-
benzylphenethylamine (trade or other name: 25I-NB);
4-Iodo-2,5-dimethoxy-N-(2,3-
methylenedioxybenzyl)phenethylamine (trade or other name: 25I-NBMD);
4-Iodo-2,5-dimethoxy-N-(2-
fluorobenzyl)phenethylamine (trade or other name: 25I-NBF);
4-Iodo-2,5-dimethoxy-N-(2-hydroxybenzyl)phenethylamine
(trade or other name: 25I-NBOH);
2,5-Dimethoxy-4-nitro-N-(2-methoxybenzyl)phenethylamine
(trade or other names: 25N-NBOMe, 2C-N-NBOMe); and
2,5-Dimethoxy-4-(n)-propyl-N-(2-
methoxybenzyl)phenethylamine (some trade
and other names: 25P-NBOMe,
2C-P-NBOMe).
(b) To the extent
Subsection (a)(2) conflicts with another provision of this subtitle or
another law, the other provision or the other law prevails.
|
SECTION 3. Subsections (a)
and (c), Section 481.103, Health and Safety Code, are amended to read as
follows:
(a) Penalty Group 2 consists
of:
(1) any quantity of the
following hallucinogenic substances, their salts, isomers, and salts of
isomers, unless specifically excepted, if the existence of these salts,
isomers, and salts of isomers is possible within the specific chemical
designation:
alpha-ethyltryptamine;
alpha-methyltryptamine;
[4-bromo-2,
5-dimethoxyamphetamine (some trade or other names: 4-bromo-2,
5-dimethoxy-alpha-methylphenethylamine; 4-bromo-2, 5-DMA);
[4-bromo-2,
5-dimethoxyphenethylamine;]
Bufotenine
(some trade and other names: 3-(beta-Dimethylaminoethyl)-5-hydroxyindole;
3-(2-dimethylaminoethyl)- 5-indolol; N, N-dimethylserotonin; 5-hydroxy-N,
N-dimethyltryptamine; mappine);
Diethyltryptamine
(some trade and other names: N, N-Diethyltryptamine, DET);
2, 5-dimethoxyamphetamine
(some trade or other names: 2, 5-dimethoxy-alpha-methylphenethylamine; 2,
5-DMA);
[2,
5-dimethoxy-4-ethylamphetamine (trade or other name: DOET);
[2,
5-dimethoxy-4-(n)-propylthiophenethylamine (trade or other name: 2C-T-7);]
Dimethyltryptamine
(trade or other name: DMT);
Dronabinol (synthetic) in
sesame oil and encapsulated in a soft gelatin capsule in a U.S. Food and
Drug Administration approved drug product (some trade or other names for
Dronabinol: (a6aR-trans)-6a,7,8,10a-tetrahydro- 6,6, 9- trimethyl-3-pentyl-6H-
dibenzo [b,d]pyran-1-ol or (-)-delta-9- (trans)-tetrahydrocannabinol);
Ethylamine Analog of
Phencyclidine (some trade or other names: N-ethyl-1-phenylcyclohexylamine,
(1-phenylcyclohexyl) ethylamine, N-(1-phenylcyclohexyl) ethylamine, cyclohexamine,
PCE);
Ibogaine (some trade or other
names: 7-Ethyl-6, 6, beta 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6,
9-methano-5H-pyrido [1', 2':1, 2] azepino [5, 4-b] indole; tabernanthe
iboga.);
Mescaline;
5-methoxy-N,
N-diisopropyltryptamine;
5-methoxy-3, 4-methylenedioxy
amphetamine;
4-methoxyamphetamine (some
trade or other names: 4-methoxy-alpha-methylphenethylamine;
paramethoxyamphetamine; PMA);
1-methyl-
4-phenyl-4-propionoxypiperidine (MPPP, PPMP);
4-methyl-2,
5-dimethoxyamphetamine (some trade and other names: 4-methyl-2,
5-dimethoxy-alpha- methylphenethylamine; "DOM"; "STP");
3,4-methylenedioxy
methamphetamine (MDMA, MDM);
3,4-methylenedioxy
amphetamine;
3,4-methylenedioxy
N-ethylamphetamine (Also known as N-ethyl MDA);
Nabilone (Another name for
nabilone: (+)-trans- 3-(1,1-dimethylheptyl)- 6,6a,
7,8,10,10a-hexahydro-1-hydroxy- 6, 6-dimethyl-9H-dibenzo[b,d] pyran-9-one;
N-benzylpiperazine (some
trade or other names: BZP; 1-benzylpiperazine);
N-ethyl-3-piperidyl
benzilate;
N-hydroxy-3,4-methylenedioxyamphetamine
(Also known as N-hydroxy MDA);
4-methylaminorex;
N-methyl-3-piperidyl
benzilate;
Parahexyl (some trade or
other names: 3-Hexyl-1-hydroxy-7, 8, 9, 10-tetrahydro-6, 6,
9-trimethyl-6H-dibenzo [b, d] pyran; Synhexyl);
1-Phenylcyclohexylamine;
1-Piperidinocyclohexanecarbonitrile
(PCC);
Psilocin;
Psilocybin;
Pyrrolidine Analog of
Phencyclidine (some trade or other names:
1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP);
Tetrahydrocannabinols, other
than marihuana, and synthetic equivalents of the substances contained in
the plant, or in the resinous extractives of Cannabis, or synthetic
substances, derivatives, and their isomers with similar chemical structure
and pharmacological activity such as:
delta-1 cis or trans
tetrahydrocannabinol, and their optical isomers;
delta-6 cis or trans
tetrahydrocannabinol, and their optical isomers;
delta-3, 4 cis or trans
tetrahydrocannabinol, and its optical isomers;
compounds of these
structures, regardless of numerical designation of atomic positions, since
nomenclature of these substances is not internationally standardized;
Thiophene Analog of
Phencyclidine (some trade or other names: 1-[1-(2-thienyl) cyclohexyl]
piperidine; 2-Thienyl Analog of Phencyclidine; TPCP, TCP);
1-pyrrolidine (some trade or
other name: TCPy);
1-(3-trifluoromethylphenyl)piperazine
(trade or other name: TFMPP); and
3,4,5-trimethoxy amphetamine;
(2) Phenylacetone (some
trade or other names: Phenyl-2-propanone; P2P, Benzymethyl ketone, methyl
benzyl ketone);
(3) unless specifically excepted
or unless listed in another Penalty Group, a material, compound, mixture,
or preparation that contains any quantity of the following substances
having a potential for abuse associated with a depressant or stimulant
effect on the central nervous system:
Aminorex (some trade or other
names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; 4,5-dihydro-5-
phenyl-2-oxazolamine);
Amphetamine, its salts,
optical isomers, and salts of optical isomers;
Cathinone (some trade or
other names: 2-amino-1-phenyl-1-propanone, alpha-aminopropiophenone,
2-aminopropiophenone);
Etorphine Hydrochloride;
Fenethylline and its salts;
Lisdexamfetamine, including
its salts, isomers, and salts of isomers;
Mecloqualone and its salts;
Methaqualone and its salts;
Methcathinone (some trade or
other names: 2-methylamino-propiophenone;
alpha-(methylamino)propriophenone; 2-(methylamino)-1-phenylpropan-1-one;
alpha-N- methylaminopropriophenone; monomethylpropion; ephedrone,
N-methylcathinone; methylcathinone; AL-464; AL-422; AL-463; and UR 1431);
N-Ethylamphetamine, its
salts, optical isomers, and salts of optical isomers; and
N,N-dimethylamphetamine (some
trade or other names: N,N,alpha-trimethylbenzeneethaneamine;
N,N,alpha- trimethylphenethylamine), its salts, optical isomers, and salts of
optical isomers; [and]
(4) any compound
structurally derived from 2-aminopropanal by substitution at the 1-position
with any monocyclic or fused-polycyclic ring system, including:
(A) compounds further
modified by:
(i) substitution in the ring
system to any extent (including alkyl, alkoxy, alkylenedioxy, haloalkyl, or
halide substituents), whether or not further substituted in the ring system
by other substituents;
(ii) substitution at the
3-position with an alkyl substituent; or
(iii) substitution at the
2-amino nitrogen atom with alkyl or dialkyl groups, or inclusion of the
2-amino nitrogen atom in a cyclic structure; and
(B) by example, compounds
such as:
4-Methylmethcathinone (Also
known as Mephedrone);
3,4-Dimethylmethcathinone
(Also known as 3,4-DMMC);
3-Fluoromethcathinone (Also
known as 3-FMC);
4-Fluoromethcathinone (Also
known as Flephedrone);
3,4-Methylenedioxy-N-methylcathinone
(Also known as Methylone);
3,4-Methylenedioxypyrovalerone
(Also known as MDPV);
alpha-Pyrrolidinopentiophenone
(Also known as alpha-PVP);
Naphthylpyrovalerone (Also
known as Naphyrone);
alpha-Methylamino-valerophenone
(Also known as Pentedrone);
beta-Keto-N-methylbenzodioxolylpropylamine
(Also known as Butylone);
beta-Keto-N-methylbenzodioxolylpentanamine
(Also known as Pentylone);
beta-Keto-Ethylbenzodioxolylbutanamine
(Also known as Eutylone); and
3,4-methylenedioxy-N-ethylcathinone
(Also known as Ethylone);
(5)
2,5-Dimethoxyphenethylamine and any compound structurally derived from
2,5-Dimethoxyphenethylamine by substitution at the 4-position of the phenyl
ring to any extent (including alkyl, alkoxy, alkylenedioxy, haloalkyl, or
halide substituents), including, by example, compounds such as:
4-Bromo-2,5-dimethoxyphenethylamine
(trade or other name: 2C-B);
4-Chloro-2,5-dimethoxyphenethylamine
(trade or other name: 2C-C);
2,5-Dimethoxy-4-methylphenethylamine
(trade or other name: 2C-D);
4-Ethyl-2,5-dimethoxyphenethylamine
(trade or other name: 2C-E);
4-Iodo-2,5-dimethoxyphenethylamine
(trade or other name: 2C-I);
2,5-Dimethoxy-4-nitrophenethylamine
(trade or other name: 2C-N);
2,5-Dimethoxy-4-(n)-propylphenethylamine
(trade or other name: 2C-P);
4-Ethylthio-2,5-dimethoxyphenethylamine
(trade or other name: 2C-T-2);
4-Isopropylthio-2,5-dimethoxyphenethylamine
(trade or other name: 2C-T-4); and
2,5-Dimethoxy-4-(n)-propylthiophenethylamine
(trade or other name: 2C-T-7); and
(6)
2,5-Dimethoxyamphetamine and any compound structurally derived from
2,5-Dimethoxyamphetamine by substitution at the 4- position of the phenyl
ring to any extent (including alkyl, alkoxy, alkylenedioxy, haloalkyl, or
halide substituents), including, by example, compounds such as:
4-Ethylthio-2,5-dimethoxyamphetamine
(trade or other name: Aleph-2);
4-Isopropylthio-2,5-dimethoxyamphetamine
(trade or other name: Aleph-4);
4-Bromo-2,5-dimethoxyamphetamine
(trade or other name: DOB);
4-Chloro-2,5-dimethoxyamphetamine
(trade or other name: DOC);
2,5-Dimethoxy-4-ethylamphetamine
(trade or other name: DOET);
4-Iodo-2,5-dimethoxyamphetamine
(trade or other name: DOI);
2,5-Dimethoxy-4-methylamphetamine
(trade or other name: DOM);
2,5-Dimethoxy-4-nitroamphetamine
(trade or other name: DON);
4-Isopropyl-2,5-dimethoxyamphetamine
(trade or other name: DOIP); and
2,5-Dimethoxy-4-(n)-propylamphetamine
(trade or other name: DOPR).
(c) To the extent Subsection
(a)(4), (5), or (6) conflicts with this subtitle or another law, the
subtitle or other law prevails.
|
SECTION 3. Section 481.103,
Health and Safety Code, is amended by amending Subsections (a) and (c) and
adding Subsection (d) to read as follows:
(a) Penalty Group 2 consists
of:
(1) any quantity of the
following hallucinogenic substances, their salts, isomers, and salts of
isomers, unless specifically excepted, if the existence of these salts,
isomers, and salts of isomers is possible within the specific chemical
designation:
5-(2-aminopropyl)benzofuran (5-APB);
6-(2-aminopropyl)benzofuran (6-APB);
5-(2-aminopropyl)-2,3-dihydrobenzofuran (5-APDB);
6-(2-aminopropyl)-2,3-dihydrobenzofuran (6-APDB);
5-(2-aminopropyl)indole (5-IT,5-API);
6-(2-aminopropyl)indole (6-IT,6-API);
1-(benzofuran-5-yl)-N-methylpropan-2-amine
(5-MAPB);
1-(benzofuran-6-yl)-N-methylpropan-2-amine
(6-MAPB);
Benzothiophenylcyclohexylpiperidine (BTCP);
8-bromo-alpha-methyl-benzo[1,2-b:4,5-b']difuran-
4-ethanamine (trade or other name: Bromo-DragonFLY);
Desoxypipradrol (2-benzhydrylpiperidine);
[alpha-ethyltryptamine;
[alpha-methyltryptamine;
[4-bromo-2,
5-dimethoxyamphetamine (some trade or other names: 4-bromo-2,
5-dimethoxy-alpha-methylphenethylamine; 4-bromo-2, 5-DMA);
[4-bromo-2,
5-dimethoxyphenethylamine;
[Bufotenine
(some trade and other names: 3-(beta- Dimethylaminoethyl)-5-hydroxyindole;
3-(2-dimethylaminoethyl)- 5- indolol; N, N-dimethylserotonin; 5-hydroxy-N,
N- dimethyltryptamine; mappine);
[Diethyltryptamine
(some trade and other names: N, N-Diethyltryptamine, DET);]
2, 5-dimethoxyamphetamine
(some trade or other names: 2, 5-dimethoxy-alpha-methylphenethylamine; 2,
5-DMA);
Diphenylprolinol (diphenyl(pyrrolidin-2-yl) methanol, D2PM);
[2,
5-dimethoxy-4-ethylamphetamine (trade or other name: DOET);
[2,
5-dimethoxy-4-(n)-propylthiophenethylamine (trade or other name: 2C-T-7);
[Dimethyltryptamine
(trade or other name: DMT);]
Dronabinol (synthetic) in
sesame oil and encapsulated in a soft gelatin capsule in a U.S. Food and
Drug Administration approved drug product (some trade or other names for
Dronabinol: (a6aR-trans)-6a,7,8,10a-tetrahydro- 6,6, 9-
trimethyl-3-pentyl-6H- dibenzo [b,d]pyran-1-ol or (-)-delta-9- (trans)-
tetrahydrocannabinol);
Ethylamine Analog of
Phencyclidine (some trade or other names: N-ethyl-1-phenylcyclohexylamine,
(1- phenylcyclohexyl) ethylamine, N-(1-phenylcyclohexyl) ethylamine,
cyclohexamine, PCE);
2-ethylamino-2-(3-methoxyphenyl)cyclohexanone (trade or other name:
methoxetamine);
Ibogaine (some trade or other
names: 7-Ethyl-6, 6, beta 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6,
9-methano-5H- pyrido [1', 2':1, 2] azepino [5, 4-b] indole; tabernanthe
iboga.);
5-iodo-2-aminoindane (5-IAI);
Mescaline;
[5-methoxy-N, N-diisopropyltryptamine;]
5-methoxy-3, 4-methylenedioxy
amphetamine;
4-methoxyamphetamine (some
trade or other names: 4-methoxy-alpha-methylphenethylamine;
paramethoxyamphetamine; PMA);
4-methoxymethamphetamine (PMMA);
2-(2-methoxyphenyl)-2-(methylamino)cyclohexanone (some trade and
other names: 2-MeO-ketamine; methoxyketamine);
1-methyl-
4-phenyl-4-propionoxypiperidine (MPPP, PPMP);
4-methyl-2,
5-dimethoxyamphetamine (some trade and other names: 4-methyl-2, 5-dimethoxy-alpha-
methylphenethylamine; "DOM"; "STP");
3,4-methylenedioxy
methamphetamine (MDMA, MDM);
3,4-methylenedioxy
amphetamine;
3,4-methylenedioxy
N-ethylamphetamine (Also known as N-ethyl MDA);
5,6-methylenedioxy-2-aminoindane (MDAI);
Nabilone (Another name for
nabilone: (+)-trans- 3-(1,1-dimethylheptyl)- 6,6a,
7,8,10,10a-hexahydro-1-hydroxy- 6, 6-dimethyl-9H-dibenzo[b,d] pyran-9-one;
N-benzylpiperazine (some
trade or other names: BZP; 1-benzylpiperazine);
N-ethyl-3-piperidyl
benzilate;
N-hydroxy-3,4-methylenedioxyamphetamine
(Also known as N-hydroxy MDA);
4-methylaminorex;
N-methyl-3-piperidyl
benzilate;
Parahexyl (some trade or
other names: 3-Hexyl-1- hydroxy-7, 8, 9, 10-tetrahydro-6, 6,
9-trimethyl-6H-dibenzo [b, d] pyran; Synhexyl);
1-Phenylcyclohexylamine;
1-Piperidinocyclohexanecarbonitrile
(PCC);
[Psilocin;
[Psilocybin;]
Pyrrolidine Analog of
Phencyclidine (some trade or other names:
1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP);
Tetrahydrocannabinols, other
than marihuana, and synthetic equivalents of the substances contained in
the plant, or in the resinous extractives of Cannabis, or synthetic
substances, derivatives, and their isomers with similar chemical structure
and pharmacological activity such as:
delta-1 cis or trans
tetrahydrocannabinol, and their optical isomers;
delta-6 cis or trans
tetrahydrocannabinol, and their optical isomers;
delta-3, 4 cis or trans
tetrahydrocannabinol, and its optical isomers; or
compounds of these
structures, regardless of numerical designation of atomic positions, since
nomenclature of these substances is not internationally standardized;
Thiophene Analog of
Phencyclidine (some trade or other names: 1-[1-(2-thienyl) cyclohexyl]
piperidine; 2-Thienyl Analog of Phencyclidine; TPCP, TCP);
1-pyrrolidine (some trade or
other name: TCPy);
1-(3-trifluoromethylphenyl)piperazine
(trade or other name: TFMPP); and
3,4,5-trimethoxy amphetamine;
(2) Phenylacetone (some
trade or other names: Phenyl-2-propanone; P2P, Benzymethyl ketone, methyl
benzyl ketone);
(3) unless specifically
excepted or unless listed in another Penalty Group, a material, compound,
mixture, or preparation that contains any quantity of the following
substances having a potential for abuse associated with a depressant or
stimulant effect on the central nervous system:
Aminorex (some trade or other
names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; 4,5-dihydro-5-
phenyl-2-oxazolamine);
Amphetamine, its salts,
optical isomers, and salts of optical isomers;
Cathinone (some trade or
other names: 2-amino-1- phenyl-1-propanone, alpha-aminopropiophenone, 2-
aminopropiophenone);
Etaqualone and its salts;
Etorphine Hydrochloride;
Fenethylline and its salts;
Lisdexamfetamine, including
its salts, isomers, and salts of isomers;
Mecloqualone and its salts;
Methaqualone and its salts;
Methcathinone (some trade or
other names: 2- methylamino-propiophenone;
alpha-(methylamino)propriophenone; 2-(methylamino)-1-phenylpropan-1-one;
alpha-N- methylaminopropriophenone; monomethylpropion; ephedrone, N-
methylcathinone; methylcathinone; AL-464; AL-422; AL-463; and UR 1431);
N-Ethylamphetamine, its
salts, optical isomers, and salts of optical isomers; and
N,N-dimethylamphetamine (some
trade or other names: N,N,alpha-trimethylbenzeneethanamine
[N,N,alpha-trimethylbenzeneethaneamine];
N,N,alpha-trimethylphenethylamine), its salts, optical isomers, and salts
of optical isomers; [and]
(4) any compound
structurally derived from 2-aminopropanal by substitution at the 1-position
with any monocyclic or fused-polycyclic ring system, including:
(A) compounds further
modified by:
(i) substitution in the ring
system to any extent (including alkyl, alkoxy, alkylenedioxy, haloalkyl, or
halide substituents), whether or not further substituted in the ring system
by other substituents;
(ii) substitution at the
3-position with an alkyl substituent; or
(iii) substitution at the
2-amino nitrogen atom with alkyl, benzyl, [or] dialkyl, or methoxybenzyl groups, or
inclusion of the 2-amino nitrogen atom in a cyclic structure; and
(B) by example, compounds
such as:
4-Methylmethcathinone (Also
known as Mephedrone);
3,4-Dimethylmethcathinone
(Also known as 3,4-DMMC);
3-Fluoromethcathinone (Also
known as 3-FMC);
4-Fluoromethcathinone (Also
known as Flephedrone);
3,4-Methylenedioxy-N-methylcathinone
(Also known as Methylone);
3,4-Methylenedioxypyrovalerone
(Also known as MDPV);
alpha-Pyrrolidinopentiophenone
(Also known as alpha-PVP);
Naphthylpyrovalerone (Also
known as Naphyrone);
alpha-Methylamino-valerophenone
(Also known as Pentedrone);
beta-Keto-N-methylbenzodioxolylpropylamine
(Also known as Butylone);
beta-Keto-N-methylbenzodioxolylpentanamine
(Also known as Pentylone);
beta-Keto-Ethylbenzodioxolylbutanamine
(Also known as Eutylone); and
3,4-methylenedioxy-N-ethylcathinone
(Also known as Ethylone);
(5) any compound structurally derived from tryptamine
(3-(2-aminoethyl)indole) or a ring-hydroxy tryptamine:
(A) by modification in any of the following ways:
(i) by substitution at the amine nitrogen atom of the sidechain to
any extent with alkyl or alkenyl groups or by inclusion of the amine
nitrogen atom of the side chain (and no other atoms of the side chain) in a
cyclic structure;
(ii) by substitution at the carbon atom adjacent to the nitrogen
atom of the side chain (alpha-position) with an alkyl or alkenyl group;
(iii) by substitution in the 6-membered ring to any extent with
alkyl, alkoxy, haloalkyl, thioaklyl, alkylenedioxy, or halide substituents;
or
(iv) by substitution at the 2-position of the tryptamine ring
system with an alkyl substituent; and
(B) including:
(i) ethers and esters of the controlled substances listed in this
subdivision; and
(ii) by example, compounds such as:
alpha-ethyltryptamine;
alpha-methyltryptamine;
Bufotenine (some trade and other names: 3-(beta- Dimethylaminoethyl)-5-hydroxyindole;
3-(2-dimethylaminoethyl)- 5- indolol; N, N-dimethylserotonin; 5-hydroxy-N,
N- dimethyltryptamine; mappine);
Diethyltryptamine (some trade and other names: N,
N-Diethyltryptamine, DET);
Dimethyltryptamine (trade or other name: DMT);
5-methoxy-N, N-diisopropyltryptamine (5-MeO-DiPT);
O-Acetylpsilocin (Trade or other name: 4-Aco-DMT);
Psilocin; and
Psilocybin;
(6)
2,5-Dimethoxyphenethylamine and any compound structurally derived from
2,5-Dimethoxyphenethylamine by substitution at the 4-position of the phenyl
ring to any extent (including alkyl, alkoxy, alkylenedioxy, haloalkyl, or
halide substituents), including, by example, compounds such as:
4-Bromo-2,5-dimethoxyphenethylamine
(trade or other name: 2C-B);
4-Chloro-2,5-dimethoxyphenethylamine
(trade or other name: 2C-C);
2,5-Dimethoxy-4-methylphenethylamine
(trade or other name: 2C-D);
4-Ethyl-2,5-dimethoxyphenethylamine
(trade or other name: 2C-E);
4-Iodo-2,5-dimethoxyphenethylamine
(trade or other name: 2C-I);
2,5-Dimethoxy-4-nitrophenethylamine
(trade or other name: 2C-N);
2,5-Dimethoxy-4-(n)-propylphenethylamine
(trade or other name: 2C-P);
4-Ethylthio-2,5-dimethoxyphenethylamine
(trade or other name: 2C-T-2);
4-Isopropylthio-2,5-dimethoxyphenethylamine
(trade or other name: 2C-T-4); and
2,5-Dimethoxy-4-(n)-propylthiophenethylamine
(trade or other name: 2C-T-7); and
(7)
2,5-Dimethoxyamphetamine and any compound structurally derived from
2,5-Dimethoxyamphetamine by substitution at the 4-position of the phenyl
ring to any extent (including alkyl, alkoxy, alkylenedioxy, haloalkyl, or
halide substituents), including, by example, compounds such as:
4-Ethylthio-2,5-dimethoxyamphetamine
(trade or other name: Aleph-2);
4-Isopropylthio-2,5-dimethoxyamphetamine
(trade or other name: Aleph-4);
4-Bromo-2,5-dimethoxyamphetamine
(trade or other name: DOB);
4-Chloro-2,5-dimethoxyamphetamine
(trade or other name: DOC);
2,5-Dimethoxy-4-ethylamphetamine
(trade or other name: DOET);
4-Iodo-2,5-dimethoxyamphetamine
(trade or other name: DOI);
2,5-Dimethoxy-4-methylamphetamine
(trade or other name: DOM);
2,5-Dimethoxy-4-nitroamphetamine
(trade or other name: DON);
4-Isopropyl-2,5-dimethoxyamphetamine
(trade or other name: DOIP); and
2,5-Dimethoxy-4-(n)-propylamphetamine
(trade or other name: DOPR).
(c) To the extent Subsection
(a)(4), (5), (6), or (7)
conflicts with another provision or this subtitle or another law,
the other provision [subtitle] or the other law
prevails. If a substance listed in this
section is also listed in another penalty group, the listing in the other
penalty group controls.
(d) If a substance listed in this section is approved by the
Federal Drug Administration, the inclusion of that substance in this
penalty group does not apply, and notwithstanding any other law, a person
may not be convicted for the manufacture or delivery of the substance under
Section 481.113 or for possession of the substance under Section 481.116.
|